UNSPSC 51101683: Semduramicin

This classification denotes an antiprotozoal agent with the molecular formula C45H76O16, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P6VXL377WL, chemically known as uk 61,689 but generally known as semduramicin, which bears US NIH Compound Identifier 71327. European Medicines Agency schedules Semduramicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10479MIG.

UNSPSC 51101683 Semduramicin is a Commodity code that appears in state and local procurement activity with limited recent relevance; the recent opportunities tagged under this code do not align with semduramicin procurement. Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, and Seminole County, Florida issued an IFB for Naloxone and Safe Drug Deactivation Systems — neither of which are semduramicin products. The tagged opportunities reflect routine pharmaceutical and emergency-response supply procurement by state health departments and county public health agencies, typically awarded through cooperative purchasing consortia or competitive IFB processes on fixed-fee pricing with initial contract terms of 12 to 24 months and optional renewals.

Recent activity appears concentrated in Florida and Illinois. The Illinois contract was a completed award with a total value of $2.999 million over three years, and the Seminole County solicitation (IFB 60459723LAS, due July 26, 2023) called for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries. The code shows no clear pattern of recent semduramicin-specific solicitations in state and local markets, and the opportunities present suggest that semduramicin procurement, if it occurs under this code, is not a current focus of state health departments or county agencies.